BD Committed To Global Health; Mitigating Blood Culture Vial Supplier Issue With FDA Collaboration, Rapid Production, And Restarting Glass Vial Production; Manual Allocation To Prioritize Clinical Needs; No Material Financial Impact Expected
BD致力於全球醫療健康；通過與FDA合作，加快生產並重新開始玻璃瓶生產來解決血液培養瓶供應商問題；手動分配來優先考慮臨床需求；預計不會對財務產生實質性影響。
